Atyr Pharma, Stock Price History
| ATYR Stock | 4.01 0.04 1.01% |
Below is the normalized historical share price chart for aTyr Pharma, extending back to May 07, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ATyr Pharma, stands at 4.01, as last reported on the 18th of March 2025, with the highest price reaching 4.32 and the lowest price hitting 3.90 during the day.
If you're considering investing in ATyr Stock, it is important to understand the factors that can impact its price. ATyr Pharma, appears to be moderately volatile, given 3 months investment horizon. aTyr Pharma, secures Sharpe Ratio (or Efficiency) of 0.0979, which signifies that the company had a 0.0979 % return per unit of risk over the last 3 months. By analyzing ATyr Pharma,'s technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please makes use of ATyr Pharma,'s Risk Adjusted Performance of 0.0712, semi deviation of 5.19, and Downside Deviation of 5.66 to double-check if our risk estimates are consistent with your expectations.
At this time, ATyr Pharma,'s Common Stock Shares Outstanding is relatively stable compared to the past year. As of 03/18/2025, Capital Stock is likely to grow to about 76.1 K, while Liabilities And Stockholders Equity is likely to drop slightly above 101.9 M. . At this time, ATyr Pharma,'s Price To Sales Ratio is relatively stable compared to the past year. As of 03/18/2025, Price Book Value Ratio is likely to grow to 0.97, though Price To Operating Cash Flows Ratio is likely to grow to (3.05). ATyr Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of May 2015 | 200 Day MA 1.7116 | 50 Day MA 1.841 | Beta 1.214 |
ATyr |
Sharpe Ratio = 0.0979
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATYR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.98 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.59 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average ATyr Pharma, is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATyr Pharma, by adding it to a well-diversified portfolio.
Price Book 1.7647 | Enterprise Value Ebitda (0.81) | Price Sales 244.9197 | Shares Float 73.8 M | Wall Street Target Price 22 |
ATyr Pharma, Stock Price History Chart
There are several ways to analyze ATyr Stock price data. The simplest method is using a basic ATyr candlestick price chart, which shows ATyr Pharma, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 20, 2025 | 4.43 |
| Lowest Price | December 16, 2024 | 3.03 |
ATyr Pharma, March 18, 2025 Stock Price Synopsis
Various analyses of ATyr Pharma,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ATyr Stock. It can be used to describe the percentage change in the price of ATyr Pharma, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ATyr Stock.| ATyr Pharma, Price Daily Balance Of Power | 0.10 | |
| ATyr Pharma, Price Action Indicator | (0.08) | |
| ATyr Pharma, Accumulation Distribution | 193,546 | |
| ATyr Pharma, Price Rate Of Daily Change | 1.01 |
ATyr Pharma, March 18, 2025 Stock Price Analysis
ATyr Stock Price History Data
The price series of ATyr Pharma, for the period between Wed, Dec 18, 2024 and Tue, Mar 18, 2025 has a statistical range of 1.41 with a coefficient of variation of 9.29. The prices are distributed with arithmetic mean of 3.58. The median price for the last 90 days is 3.59. The company had 1:14 stock split on 1st of July 2019.| Open | High | Low | Close | Volume | ||
| 03/17/2025 | 3.99 | 4.32 | 3.90 | 4.01 | 1,990,764 | |
| 03/14/2025 | 3.65 | 4.28 | 3.65 | 3.97 | 2,400,704 | |
| 03/13/2025 | 3.55 | 4.04 | 3.53 | 3.99 | 1,830,267 | |
| 03/12/2025 | 3.10 | 3.71 | 3.10 | 3.55 | 2,123,033 | |
| 03/11/2025 | 3.10 | 3.27 | 2.98 | 3.07 | 2,306,400 | |
| 03/10/2025 | 3.32 | 3.39 | 3.10 | 3.10 | 1,461,430 | |
| 03/07/2025 | 3.28 | 3.73 | 3.27 | 3.40 | 2,881,767 | |
| 03/06/2025 | 3.11 | 3.17 | 2.95 | 3.08 | 1,199,195 | |
| 03/05/2025 | 3.15 | 3.26 | 3.07 | 3.15 | 1,825,585 | |
| 03/04/2025 | 3.24 | 3.25 | 2.71 | 3.03 | 3,112,100 | |
| 03/03/2025 | 3.98 | 4.01 | 3.29 | 3.30 | 1,780,570 | |
| 02/28/2025 | 3.86 | 3.96 | 3.70 | 3.96 | 954,700 | |
| 02/27/2025 | 3.97 | 4.14 | 3.86 | 3.87 | 1,312,200 | |
| 02/26/2025 | 3.79 | 3.92 | 3.69 | 3.87 | 1,368,094 | |
| 02/25/2025 | 3.81 | 3.89 | 3.52 | 3.79 | 3,962,396 | |
| 02/24/2025 | 4.35 | 4.40 | 3.83 | 3.83 | 1,922,900 | |
| 02/21/2025 | 4.56 | 4.66 | 4.31 | 4.32 | 1,752,230 | |
| 02/20/2025 | 4.48 | 4.58 | 4.11 | 4.43 | 2,095,300 | |
| 02/19/2025 | 3.86 | 4.29 | 3.85 | 4.25 | 3,749,907 | |
| 02/18/2025 | 3.58 | 3.82 | 3.52 | 3.79 | 1,297,109 | |
| 02/14/2025 | 3.61 | 3.65 | 3.38 | 3.41 | 1,054,425 | |
| 02/13/2025 | 3.61 | 3.72 | 3.51 | 3.59 | 496,100 | |
| 02/12/2025 | 3.67 | 3.81 | 3.60 | 3.60 | 1,324,588 | |
| 02/11/2025 | 3.75 | 3.75 | 3.60 | 3.71 | 511,070 | |
| 02/10/2025 | 3.93 | 3.93 | 3.69 | 3.77 | 638,000 | |
| 02/07/2025 | 3.86 | 3.98 | 3.78 | 3.90 | 743,631 | |
| 02/06/2025 | 3.95 | 3.99 | 3.84 | 3.87 | 527,920 | |
| 02/05/2025 | 3.81 | 3.96 | 3.73 | 3.94 | 768,236 | |
| 02/04/2025 | 3.61 | 3.87 | 3.57 | 3.81 | 878,800 | |
| 02/03/2025 | 3.50 | 3.61 | 3.33 | 3.57 | 1,300,800 | |
| 01/31/2025 | 3.75 | 3.95 | 3.75 | 3.86 | 692,100 | |
| 01/30/2025 | 3.66 | 3.83 | 3.63 | 3.74 | 571,600 | |
| 01/29/2025 | 3.49 | 3.74 | 3.48 | 3.63 | 492,200 | |
| 01/28/2025 | 3.50 | 3.54 | 3.38 | 3.46 | 394,000 | |
| 01/27/2025 | 3.57 | 3.69 | 3.42 | 3.46 | 383,500 | |
| 01/24/2025 | 3.56 | 3.68 | 3.55 | 3.59 | 448,200 | |
| 01/23/2025 | 3.46 | 3.59 | 3.34 | 3.56 | 644,800 | |
| 01/22/2025 | 3.63 | 3.69 | 3.40 | 3.50 | 667,800 | |
| 01/21/2025 | 3.65 | 3.65 | 3.46 | 3.63 | 558,800 | |
| 01/17/2025 | 3.79 | 3.83 | 3.60 | 3.61 | 670,200 | |
| 01/16/2025 | 3.50 | 3.81 | 3.45 | 3.75 | 1,656,500 | |
| 01/15/2025 | 3.39 | 3.49 | 3.31 | 3.46 | 901,800 | |
| 01/14/2025 | 3.30 | 3.39 | 3.17 | 3.29 | 856,200 | |
| 01/13/2025 | 3.50 | 3.50 | 3.25 | 3.29 | 1,085,400 | |
| 01/10/2025 | 3.72 | 3.73 | 3.52 | 3.53 | 885,400 | |
| 01/08/2025 | 3.88 | 3.89 | 3.61 | 3.74 | 781,600 | |
| 01/07/2025 | 4.00 | 4.07 | 3.77 | 3.89 | 690,700 | |
| 01/06/2025 | 4.15 | 4.22 | 3.89 | 3.97 | 1,359,700 | |
| 01/03/2025 | 4.00 | 4.02 | 3.83 | 3.98 | 1,116,800 | |
| 01/02/2025 | 3.69 | 3.97 | 3.63 | 3.91 | 1,397,800 | |
| 12/31/2024 | 3.55 | 3.68 | 3.47 | 3.62 | 665,800 | |
| 12/30/2024 | 3.70 | 3.72 | 3.44 | 3.51 | 850,300 | |
| 12/27/2024 | 3.86 | 3.98 | 3.64 | 3.74 | 1,051,300 | |
| 12/26/2024 | 3.43 | 3.77 | 3.33 | 3.77 | 1,047,800 | |
| 12/24/2024 | 3.42 | 3.45 | 3.28 | 3.42 | 371,700 | |
| 12/23/2024 | 3.40 | 3.51 | 3.30 | 3.38 | 754,400 | |
| 12/20/2024 | 3.15 | 3.35 | 3.13 | 3.35 | 1,626,700 | |
| 12/19/2024 | 3.18 | 3.26 | 3.05 | 3.15 | 1,378,900 | |
| 12/18/2024 | 3.14 | 3.20 | 3.09 | 3.15 | 1,136,700 | |
| 12/17/2024 | 3.07 | 3.26 | 3.04 | 3.08 | 746,500 | |
| 12/16/2024 | 3.07 | 3.23 | 3.02 | 3.03 | 1,084,300 |
About ATyr Pharma, Stock history
ATyr Pharma, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ATyr is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in aTyr Pharma, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ATyr Pharma, stock prices may prove useful in developing a viable investing in ATyr Pharma,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 61.6 M | 64.7 M |
ATyr Pharma, Quarterly Net Working Capital |
|
ATyr Pharma, Stock Technical Analysis
ATyr Pharma, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
ATyr Pharma, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ATyr Pharma,'s price direction in advance. Along with the technical and fundamental analysis of ATyr Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ATyr to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0712 | |||
| Jensen Alpha | 0.569 | |||
| Total Risk Alpha | 1.14 | |||
| Sortino Ratio | 0.0916 | |||
| Treynor Ratio | 0.2796 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.